Pfiz­er and Ab­b­Vie oral mi­graine drugs earn top spots with physi­cians, sur­vey finds

Oral drugs have raced to the front of the pack in the crowd­ed mi­graine ther­a­py space and ap­pear to be stay­ing put with physi­cians.

Pri­ma­ry care physi­cians in par­tic­u­lar are pre­scrib­ing Pfiz­er’s Nurtec and Ab­b­Vie’s Ubrelvy and Qulip­ta, ac­cord­ing to Spher­ix Glob­al In­sights’ lat­est quar­ter­ly sur­vey of mi­graine drug pre­scribers. Pri­ma­ry docs re­port­ed more than 27% of pa­tients on Nurtec for acute use and about 20% for pre­ven­ta­tive care.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER